AD patients have abnormal regulation of ribosomal proteins (e.g., RPS5, RPS6, RPS7, RPS13), initiation factors (eIF2α, eIF5), and elongation factors (eEF2). This evidence concerns the gene RPS5 and Alzheimer disease.